Akebia Therapeutics Ratios (2013-2026) | AKBA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)	17.82%	67.30%	107.62%	44.15%	57.05%	39.91%	122.30%	72.06%	85.33%	78.60%	66.79%	92.04%	60.94%	62.16%	-1.94%	86.70%	84.12%	84.03%	78.25%	77.05%
EBT Margin (Quarter)	-159.32%	-123.00%	46.31%	-156.25%	67.05%	-111.58%	-11.66%	-67.18%	-19.82%	-34.46%	1.09%	-55.16%	-19.66%	-53.54%	-49.04%	10.66%	0.40%	1.97%	-19.50%	-16.67%
EBIT Margin (Quarter)	-149.95%	-112.57%	42.97%	-144.01%	78.68%	-103.47%	-8.73%	-63.98%	-15.96%	-31.00%	2.45%	-45.81%	-19.99%	-33.41%	-30.77%	23.57%	22.55%	7.57%	-14.84%	-8.77%
EBITDA Margin (Quarter)	-156.94%	-122.13%	45.94%	-153.51%	68.00%	-111.05%	-10.88%	-67.18%	-19.82%	-34.46%	1.09%	-55.16%	-19.66%	-53.54%	-49.04%	10.66%	0.40%	0.92%	-21.25%	-16.91%
Operating Margin (Quarter)	-149.95%	-112.57%	42.97%	-144.01%	78.68%	-103.47%	-8.73%	-63.98%	-15.96%	-31.00%	2.45%	-45.81%	-19.99%	-33.41%	-30.77%	23.57%	22.55%	7.57%	-14.84%	-8.77%
Net Margin (Quarter)	-156.93%	-122.13%	46.31%	-153.51%	68.00%	-111.05%	-11.66%	-67.18%	-19.82%	-34.46%	1.09%	-55.16%	-19.66%	-53.54%	-49.04%	10.66%	0.40%	0.92%	-21.25%	-16.91%
FCF Margin (Quarter)	-119.33%	-115.41%	41.30%	-52.53%	-70.79%	69.39%	-98.02%	-43.84%	6.44%	-17.05%	-4.11%	-59.59%	-23.13%	-17.89%	-9.61%	-23.73%	35.57%	47.69%	53.90%	-39.72%
Efficiency
Inventory Average (Quarter)	41.35M	35.79M	35.16M	38.86M	40.66M	42.73M	33.41M	20.99M	20.66M	19.67M	17.07M	20.61M	24.70M	22.18M	18.37M	17.99M	18.22M	17.68M	17.13M	14.30M
Assets Average (Quarter)	620.28M	607.07M	565.81M	535.57M	535.84M	487.07M	400.15M	318.49M	267.32M	244.35M	238.35M	233.59M	222.84M	213.67M	213.91M	265.43M	327.89M	354.87M	370.36M	369.54M
Equity Average (Quarter)	194.26M	155.89M	105.58M	48.29M	40.76M	33.60M	6.74M	-6.95M	-22.96M	-33.11M	-35.00M	-28.92M	-30.51M	-42.08M	-49.79M	-12.30M	26.90M	35.41M	37.10M	29.99M
Invested Capital (Quarter)	174.63M	137.15M	171.55M	120.43M	157.09M	74.21M	71.31M	4.88M	-2.81M	-31.42M	4.10M	2.89M	4.28M	-12.05M	-10.49M	71.09M	76.29M	89.23M	80.86M	76.27M
Asset Utilization Ratio (Quarter)	0.23	0.29	0.00	-0.02	-0.03	-0.04	0.47	0.59	0.75	0.79	0.82	0.80	0.78	0.80	0.75	0.70	0.62	0.63	0.64	0.63
Leverage & Solvency
Debt to Equity (Quarter)	0.55	0.71	1.32	4.33	1.67	7.98	12.63	-2.63	-1.59	-1.08	-1.13	-1.11	-1.13	-0.76	-0.79	1.89	1.61	1.15	1.48	1.79
Debt Ratio (Quarter)	0.16	0.16	0.18	0.18	0.19	0.15	0.19	0.18	0.17	0.18	0.14	0.13	0.17	0.19	0.18	0.15	0.14	0.13	0.13	0.13
Equity Ratio (Quarter)	0.29	0.23	0.14	0.04	0.11	0.02	0.01	-0.07	-0.11	-0.17	-0.13	-0.12	-0.15	-0.24	-0.22	0.08	0.08	0.11	0.09	0.08
Valuation
Enterprise Value (Quarter)	-246.99M	-207.20M	-149.80M	-174.56M	-143.90M	-144.80M	-90.47M	-57.00M	-53.60M	-46.53M	-42.92M	-41.96M	-39.50M	-34.02M	-51.87M	-113.40M	-137.31M	-166.40M	-184.84M	-162.60M
Return Ratios
Return on Sales (Quarter)	-0.02%	-0.01%	0.00%	-0.02%	0.01%	-0.01%	0.00%	-0.01%	0.00%	0.00%	0.00%	-0.01%	0.00%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Capital Employed (Quarter)	-63.29%	-68.10%	-86.79%	-93.53%	-48.83%	-48.05%	-29.85%	-20.27%	-51.31%	-31.88%	-33.40%	-21.30%	-30.57%	-23.51%	-37.95%	-12.64%	0.38%	8.01%	11.33%	2.70%
Return on Invested Capital (Quarter)																		0.00%	0.00%	0.00%
Return on Assets (Quarter)	0.00%	0.00%	-0.01%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (Quarter)	-0.02%	-0.02%	-0.03%	-0.06%	-0.04%	-0.05%	-0.14%	0.08%	0.04%	0.02%	0.01%	0.01%	0.01%	0.01%	0.01%	0.04%	-0.01%	0.00%	0.00%	-0.01%

Research Tools

Akebia Therapeutics Ratios (2013-2026) | AKBA

Create an account

Sign In

Reset Password